COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 491.3 | 4 | 0058-0370 | 645.70 | 369.78 | 240 | 56.53 | 0.944 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 401.8 | 4 | 0059-0374 | 765.64 | 375.08 | 305 | 63.60 | 0.948 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 413.7 | 4 | 0060-0377 | 230.62 | 377.83 | 321 | 67.84 | 0.876 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 432.6 | 4 | 0061-0375 | 75.09 | 374.82 | 228 | 58.87 | 0.827 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 458.5 | 4 | 0062-0397 | 347.58 | 396.96 | 251 | 61.01 | 0.847 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 447.7 | 4 | 0063-0400 | 196.29 | 400.36 | 253 | 59.11 | 0.910 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 320.1 | 4 | 0064-0399 | 845.43 | 399.14 | 274 | 61.11 | 0.922 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 386.2 | 4 | 0065-0405 | 765.45 | 405.15 | 309 | 65.60 | 0.902 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 421.4 | 4 | 0066-0407 | 710.17 | 407.47 | 313 | 64.43 | 0.948 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 444.2 | 4 | 0067-0411 | 327.72 | 411.45 | 279 | 64.77 | 0.836 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 400.1 | 4 | 0068-0425 | 935.39 | 425.27 | 246 | 64.28 | 0.748 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 374.0 | 4 | 0069-0426 | 227.43 | 425.84 | 276 | 63.60 | 0.857 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2512.2 | 4 | 0070-0433 | 826.67 | 433.62 | 366 | 73.01 | 0.863 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 283.1 | 4 | 0071-0433 | 792.34 | 434.04 | 296 | 65.26 | 0.874 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 404.7 | 4 | 0072-0439 | 880.69 | 439.79 | 390 | 75.84 | 0.852 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 336.8 | 4 | 0073-0458 | 342.98 | 457.95 | 303 | 68.53 | 0.811 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 367.3 | 4 | 0074-0466 | 560.47 | 466.09 | 336 | 71.01 | 0.837 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 2326.9 | 4 | 0075-0477 | 753.31 | 477.02 | 509 | 85.50 | 0.875 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 404.1 | 4 | 0076-0487 | 519.08 | 487.44 | 347 | 70.43 | 0.879 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 428.3 | 4 | 0077-0489 | 901.11 | 489.35 | 224 | 59.70 | 0.790 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 340.7 | 4 | 0078-0497 | 148.51 | 496.66 | 310 | 65.60 | 0.905 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 337.5 | 4 | 0079-0504 | 288.85 | 504.09 | 327 | 67.26 | 0.908 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 479.9 | 4 | 0080-0502 | 21.26 | 502.29 | 265 | 65.60 | 0.774 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 335.6 | 4 | 0081-0502 | 230.11 | 502.30 | 295 | 68.43 | 0.792 |
COLO 858 | Vemurafenib | 1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 373.9 | 4 | 0082-0507 | 702.74 | 507.36 | 250 | 59.94 | 0.874 |